Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5643_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
14 Мб
Скачать
☆
14 Herbal Pharmacopeia

1.12 SUPERMOLECULES AND NANOTECHNOLOGY

Supermolecules, formed through the binding of two or more molecules via intermolecular interac­tions, create intricate and organized aggregates with unique microstructures and macroscopic prop­erties. The concept of the supermolecule emerged in the mid- 1930s, with supramolecular chemistry being formally introduced by French scientist Jean- Marie Lehn in 1987. This eld emphasizes molecular aggregates held together by non- covalent interactions, highlighting the pivotal role of these interactions.
At present, supermolecules are primarily classied into two categories: those that arise from the self- assembly of small molecules and those that are made up of small molecules combined with inorganic complexes. It is worth noting that numerous supermolecules resulting from the self­assembly of small molecules have been discovered in Traditional Chinese Medicines (TCMs) [52]. Examples include combinations such as berberine with rhein, berberine with baicalin, and berberine with cinnamic acid. These combinations have shown enhanced bioactivity and reduced toxicity compared to their individual components.
The superior bioactivity and effective toxicity reduction of these supermolecules contribute to more stable drug delivery systems. However, the stability of supermolecules remains a concern due to their dependence on non- covalent forces, which can lead to variations in activity, toxicity, and stability. Consequently, they hold potential as quality markers (Q- markers) for ensuring the safety and efcacy of herbal medicinal products (HMPs). Despite their potential, several challenges per­sist. The complexity of TCM compositions and current limitations in isolating their active ingredi­ents make it difcult to identify and extract active supermolecules. Furthermore, while supermolecules demonstrate promising in vitro and in vivo activity, it is uncertain whether they maintain their super­molecular form within the body. Additionally, detecting supermolecules poses challenges, as chro­matographic separation techniques can disrupt their structures. Advances in mass spectrometry imaging may provide new methods for detecting and localizing supermolecules in vivo [53]. Given their pharmacological potential, supermolecules are anticipated to receive increased research focus and become integral to future HMP quality control practices. As small molecules dominated the past and macromolecules are the current focus, supermolecules are expected to be the next focal point, underscoring their signicance alongside small molecules and macromolecules in quality control practices.
1.13 PHARMACOVIGILANCE IN HERBAL MEDICINE: CHALLENGES
AND GLOBAL PERSPECTIVES
The relentless quest to combat life- threatening diseases has spurred the development of diverse treatment approaches, with cancer therapy standing out as a key area of focus. Despite the progress in conventional cancer treatments, these therapies face several signicant limitations. Issues such as restricted drug accessibility to various tissues, the need for high dosages, undesirable cytotoxic­ity, the emergence of drug resistance, and non- specic targeting highlight the urgent need for novel technologies to overcome the deciencies of traditional cancer treatments [54].
Nanotechnology has emerged as a transformative force, facilitating the creation of advanced nanoparticulate drug delivery systems. Modern innovations, including polymeric nanocapsules, liposomes, nanoemulsions, nanoparticles, and solid lipid nanoparticles, offer substantial improve­ments in drug delivery. These systems enhance drug solubility and bioavailability, increase pharma­cological activity, optimize tissue distribution, and mitigate toxicity from prolonged exposure. Additionally, they provide protection against physical and chemical degradation, addressing the limitations of conventional drugs, which often suffer from poor release proles and absorption issues.
In Europe, the use of herbal medicines is steeped in a rich tapestry of traditions from Chinese, Indian, North and South American, African, and European systems. This diversity poses signicant
Introduction to Herbal Pharmacopeia 15
challenges for herbal pharmacovigilance, particularly in selecting appropriate naming systems for herbs—whether botanical, common, pharmaceutical, or herbal drug names—and in validating the botanical identity of herbal ingredients. Unlike synthetic medicines, these challenges are not easily addressed by existing pharmacovigilance systems or electronic data systems originally designed for pharmaceuticals (e.g., DynPage, UMC) [55]. Problems such as naming inconsistencies or adultera­tions do not integrate seamlessly into current pharmacovigilance frameworks. While adjustments to these systems may be necessary, establishing entirely separate systems for herbal medicines could introduce additional complexities and confusion, potentially reducing reporting rates.
The global rise in herbal medicine use underscores a signicant gap in safety information across diverse patient populations. Variations in critical factors such as pharmacogenomics, metabolization proles, and gut microora composition can profoundly impact both the bioactivity and safety of these medicines. To develop effective and safe guidelines for herbal medicine use, robust pharmaco­vigilance is crucial for collecting reliable safety data. Although herbal medicine is gaining increas­ing global acceptance, the cultivation of medicinal plants encounters signicant obstacles. The infrastructure for supporting herbal medicine industries remains underdeveloped, with shortcom­ings in quality control and monitoring of medicinal toxicity [21]. There is limited oversight of side effects and a lack of international standards governing the methods and dosages of herbal medicines [56]. Additionally, there is a lack of public awareness about the risks associated with self- medication and the possible interactions between herbal and pharmaceutical drugs. The signicance of using herbal remedies correctly and at the right time is frequently underestimated, which could greatly affect their effectiveness in healthcare [17].

1.14 FUTURE PROSPECTS OF NANOMEDICINES

The escalating global interest in herbal remedies and natural products has spurred signicant advancements in the eld of nanomedicine, particularly within drug delivery systems. Numerous institutions are dedicated to both fundamental research and clinical trials aimed at enhancing these systems. The focus is on delivering precise dosages to targeted sites within the body, which not only mitigates side effects such as toxicity and hypersensitivity but also bolsters overall patient health and vitality [57].
Looking ahead, incorporating herbal nanoparticles into cancer drug delivery is a highly promis­ing research direction. This advancement could yield groundbreaking outcomes. With the advance­ment of science and technology, nanoparticles are becoming more common in various aspects of daily life, often bringing about transformative effects that may not be immediately noticeable [49]. The future of nanotechnology in herbal drug delivery appears exceptionally promising, with inter­disciplinary collaborations set to elevate nanoscience as a leading treatment modality in the near future.
The use of herbal nanoparticles in the treatment of serious conditions like cancer, diabetes, and anemia is expected to garner signicant research interest. As natural products and herbal treatments are increasingly combined with nanocarriers, there is anticipated to be a notable enhancement in the effectiveness of drug delivery systems [58]. This progress will further solidify nanotechnology’s pivotal role in modern medicine.

1.15 CONCLUSION

In the dynamic realm of drug discovery and therapeutic advancement, the fusion of herbal phar­macopeia with modern scientic innovations, particularly nanotechnology, presents an exciting frontier. This chapter has delved into the historical importance and enduring relevance of herbal medicine, highlighting its potential to tackle contemporary health issues. By integrating ancient wisdom with cutting- edge technologies like nanoscale drug delivery systems, we can unlock new levels of efcacy, safety, and precision in herbal treatments. The convergence of traditional herbal
16 Herbal Pharmacopeia
knowledge with modern nanotechnology not only improves the bioavailability and targeted delivery of herbal compounds but also paves the way for the development of novel therapeutic agents. This integration represents a balanced approach that merges time- honored natural remedies with rigor­ous scientic research, paving the way for more personalized and effective healthcare solutions. As we further explore the extensive repository of herbal knowledge, it is vital to uphold principles of sustainability, ethical sourcing, and respect for indigenous practices. The future of herbal pharma­copeia hinges on its ability to innovate while preserving the rich cultural heritage that underpins it. By doing so, we ensure that herbal medicine remains a vital component of global healthcare, contributing to the well- being of future generations. This chapter introduces the vast possibilities at the intersection of herbal pharmacopeia and nanotechnology, setting the stage for subsequent explo­ration and discovery. The journey of blending ancient traditions with modern science is not merely about harnessing the therapeutic potential of herbs but about redening the future of medicine itself.

REFERENCES

1. Bhowmick, S., Singh, T., & Chauhan, P. S. (2024). Harnessing the power of aromatic and medicinal
plants for natural product innovation. In Medicinal and Aromatic Plants: Current Research Status, Value- Addition to Their Waste, and Agro- Industrial Potential (Vol I, pp. 211–222). Springer Nature Switzerland.
2. Devangan, P., Bajad, G., Loharkar, S., Wadate, N., Gollapalli, S., Dutta, T., & Madan, J. (2024). Quality-
by- design strategy for developing novel herbal products. In Introduction to Quality by Design (QbD) From Theory to Practice (pp. 263–295). Springer Nature Singapore.
3. Shokeen, A., Dhawan, B., Sarwat, M., & Gupta, S. (2024). Advancement in herbal drugs for the treat-
ment of Parkinson’s disease. In Targeting Angiogenesis, Inammation, and Oxidative Stress in Chronic Diseases (pp. 251–276). Academic Press.
4. Verma, R., Bhardwaj, S., & Gupta, J. (2018). Broad view of nano herbal medicine. International Journal
of Advanced Research in Science and Technology, 5(2), 1–5.
5. Rh, R. U. (2015). Traditional herbal medicine, pharmacognosy, and pharmacopoeial standards: A discus-
sion at the crossroads. In Evidence- based validation of herbal medicine (pp. 45–85). Elsevier.
6. Majidzadeh, H., Araj- Khodaei, M., Ghaffari, M., Torbati, M., Dolatabadi, J. E. N., & Hamblin, M. R.
(2020). Nano- based delivery systems for berberine: A modern anti- cancer herbal medicine. Colloids and Surfaces B: Biointerfaces, 194, 111188.
7. Zahoor, I., Mir, T. A., Ganaie, T. A., Allai, F. M., Ayoub, W. S., & Farooq, S. (2024). Antidiabetic poten-
tial from selected Himalayan underutilized herbs: A review. Food and Humanity, 100297. https://doi. org/10.1016/j.foohum.2024.100297
8. Hu, D., Gao, J., Yang, X., & Liang, Y. (2021). Chinese pharmacopoeia revisited: A review of anti-
depression herbal sources. Natural Product Communications, 16(12), 1934578X211059312.
9. Jurel, P., Bahadur, S., & Bajpai, M. (2024). Emerging trends in pharmacological and therapeutic potential
of glycyrrhizic acids: Traditional and Nanotechnological approach. Pharmacological Research - Modern Chinese Medicine, 100461. https://doi.org/10.1016/j.prmcm.2024.100461
10. Khan, E., Kesari, K. K., & Arif, J. M. (2018). Importance, challenges and future of traditional herbal
medicines for cancer care. Biochemical and Cellular Archives, 18(1), 1–9.
11. Sen, S., & Chakraborty, R. (2015). Toward the integration and advancement of herbal medicine: A focus
on traditional Indian medicine. Botanics: Targets and Therapy, 2005, 33–44.
12. Kumar, K. S. (2015). Herbal Pharmacopoeias—An overview of international and Indian representation.
Journal of Ayurvedic and Herbal Medicine, 1, 59–60.
13. Cheng, W., Li, S., Han, J., Su, J., & Cai, W. (2022). Supermolecules as a quality markers of herbal
medicinal products. Heliyon, 8(12), e12497.
14. Elena, D. L. (2012). Pharmacognostic methods for analysis of herbal drugs, According to European
Pharmacopoeia. Promising Pharmaceuticals, 2012, 38–62.
15. Kitanov, G., Karcheva, D., & Lukova, P. (2015). Comparative analysis of monographs on herbal drugs
and herbal drug preparations included in the European Pharmacopoeia (Ph. Eur. 8). Annales UMCS, Pharmacia, 62, 20–27.
16. Kumari, R., & Kotecha, M. (2016). A review on the standardization of herbal medicines. International
Journal of Pharmaceutical Sciences and Research, 7(2), 97–106.
Introduction to Herbal Pharmacopeia 17
17. Shikov, A. N., Tsitsilin, A. N., Pozharitskaya, O. N., Makarov, V. G., & Heinrich, M. (2017). Traditional and
current food use of wild plants listed in the Russian Pharmacopoeia. Frontiers in Pharmacology, 8, 841.
18. Benedec, D., Oniga, I., & Hanganu, D. (2017). Medicinal herbs in Romanian Pharmacopoeias- 155 years
of history. Hop and Medicinal Plants, 25, 69–78.
19. Etkin, N. L. (1981). A Hausa herbal pharmacopoeia: Biomedical evaluation of commonly used plant
medicines. Journal of Ethnopharmacology, 4(1), 75–98.
20. Ge, W., Gao, Y., He, L., Jiang, Z., Zeng, Y., Yu, Y., & Zhou, F. (2024). Developing Chinese herbal- based
functional biomaterials for tissue engineering. Heliyon. 10, e27451.
21. Lu, Y., Luo, Q., Jia, X., Tam, J. P., Yang, H., Shen, Y., & Li, X. (2023). Multidisciplinary strategies to
enhance therapeutic effects of avonoids from Epimedii Folium: Integration of herbal medicine, enzyme engineering, and nanotechnology. Journal of Pharmaceutical Analysis, 13(3), 239–254.
22. Saxena, S. (2020). Medicinal biome: From tradition to modernized pharmacy. Natural Products and
Their Utilization Pattern (pp. 43–70), Nova Science Publishers.
23. Krishnaswamy, S. (2024). Phytopharmaceutical biotechnology: Integration of botany, pharmacology and
plant biotechnology to deliver the best therapeutic potential of herbs. In Concepts in Pharmaceutical Biotechnology and Drug Development (pp. 437–464). Springer Nature Singapore.
24. Balkrishna, A., Solleti, S. K., Singh, H., Tomer, M., Sharma, N., & Varshney, A. (2020). Calcio- herbal
formulation, Divya- Swasari- Ras, alleviates chronic inammation and suppresses airway remodelling in mouse model of allergic asthma by modulating pro- inammatory cytokine response. Biomedicine & Pharmacotherapy, 126, 110063.
25. Farooq, S., Mehmood, Z., Qais, F. A., Khan, M. S., & Ahmad, I. (2019). Nanoparticles in ayurvedic
medicine: Potential and prospects. In New Look to Phytomedicine (pp. 581–596). Academic Press.
26. Usman, M. R. M., Jain, B. V., Patil, K. G., & Sonawane, Y. P. (2023). Concomitant Use of Local Herbal
Cornucopia in Providing Relief from Respiratory Disorders. Journal of Survey in Fisheries Sciences, 10(2S), 1054–1061.
27. Kunle, O. F., Egharevba, H. O., & Ahmadu, P. O. (2012). Standardization of herbal medicines- A review.
International Journal of Biodiversity and Conservation, 4(3), 101–112.
28. Bilia, A. R. (2015). Herbal medicinal products versus botanical- food supplements in the European mar-
ket: State of art and perspectives. Natural Product Communications, 10(1), 1934578X1501000130.
29. Patil, R. Y., Patil, S. A., Chivate, N. D., & Patil, Y. N. (2018). Herbal drug nanoparticles: Advancements
in herbal treatment. Research Journal of Pharmacy and Technology, 11(1), 421–426.
30. Marella, S., & Tollamadugu, N. V. K. V. P. (2018). Nanotechnological approaches for the development
of herbal drugs in treatment of diabetes mellitus—A critical review. IET Nanobiotechnology, 12(5), 549–556.
31. Ali, H., Alvi, A., Nawab, A., Salman, S., Zafar, F., & Naveed, S. (2019). Novel drug delivery approaches
in formulation development; stability considerations and quality features of herbal products. RADS Journal of Pharmacy and Pharmaceutical Sciences, 7(3), 155–164.
32. Pavithra, K., & Manimaran, V. (2024). A Review of Safety, Quality, Regulation, and Delivery Approaches
for Phytopharmaceuticals. Jordan Journal of Pharmaceutical Sciences, 17(2), 316–332.
33. Qadir, A., Khan, N., Singh, S. P., Akhtar, J., & Arif, M. (2015). Nanotechnological approaches to herbal
drugs used in cancer therapy. International Journal of Pharmaceutical Sciences and Research, 6(10), 4137.
34. Saidakbarovich, R. K., Kizi, S. I. B., & Kizi, R. S. U. (2023). Development of technology of production
and quality assessment of drug substance" dry extract of scutellaria iscanderi l. with silver nanoparticles". Frontline Medical Sciences and Pharmaceutical Journal, 3(03), 1–16.
35. Choudhary, N., & Sekhon, B. S. (2011). An overview of advances in the standardization of herbal drugs.
Journal of Pharmaceutical Education and Research, 2(2), 55.
36. Bavya, S., Nagalakshmi, R., & Sundari, U. T. (2022). Anatomical and preliminary phytochemical evalu-
ation of the medicinal plant: Enicostemma littorale. Medicina, 2022, 31.
37. Eloff, J. N., Gurib- Fakim, A., & Phillips, L. D. (2010). African Herbal Pharmacopoeia (Vol. 53).
T.Brendler (Ed.). Association for African Medicinal Plants Standards.
38. Pallavi, M. C., & Aarti, V. P. (2020). Herbal nanogel formulation: A novel approach. Journal of Science&
Technology (JST), 5(5), 149–153.
39. Fursenco, C., Dragalin, E. A., Calalb, T., & Uncu, L. (2023). Comparative assessment of pharmacopoeia
requirements regarding the standardization of herbal drugs. In Directii de reformare a sistemului farma- ceutic din perspectiva cursului european al Republicii Moldova (pp. 104–116).
18 Herbal Pharmacopeia
40. De, A., De, S., Saha, N., Das, B., Naskar, S., & Samanta, A. (2024). Pharmacopoeias, national formulary
and extra pharmacopoeia. In Dosage Forms, Formulation Developments and Regulations (pp. 83–98). Academic Press.
41. Bik- San Lau, C., Yue, G. G. L., Lau, K. M., Chan, Y. Y., Shaw, P. C., Kwok, H. F., & Wong, L. S. (2019).
Method establishment for upgrading chemical markers in pharmacopoeia to bioactive markers for biologi­cal standardization of traditional Chinese medicine. Journal of Traditional and Complementary Medicine, 9(3), 179–183.
42. Kumar, M., Ranjan, R., Dandapat, S., Srivastava, R., Raipat, B. S., & Sinha, M. P. (2023). Green nano-
technology: Synthesis of silver nanoparticles using aqueous leaf extracts of Swertia chirayita and Punica Granatum. The Bioscan, 18(3), 167–176.
43. Prakash, J., Srivastava, S., Ray, R. S., Singh, N., Rajpali, R., & Singh, G. N. (2017). Current status of
herbal drug standards in the Indian pharmacopeia. Phytotherapy Research, 31(12), 1817–1823.
44. Izah, S. C., Ogidi, O. I., Ogwu, M. C., Salimon, S. S., Yusuf, Z. M., Akram, M., … & Iyingiala, A. A.
(2024). Historical Perspectives and Overview of the Value of Herbal Medicine. In Herbal Medicine Phytochemistry: Applications and Trends (pp. 3–35). Springer International Publishing.
45. Ahlawat, J., Verma, N., & Sehrawat, A. R. (2014). Globalisation of herbal drugs: A bliss and concern.
International Journal of Science and Research, 3(11), 466–474.
46. Pathak, A., Gupta, A. P., & Pandey, P. (2024). Herbal medicine and sustainable development challenges
and opportunities. Herbal Medicine Phytochemistry: Applications and Trends, 1–26.
47. Sonu Ambwani, S. A., Roopali Tandon, R. T., Ambwani, T. K., & Malik, Y. S. (2018). Current knowledge
of nano delivery systems and their benecial applications in enhancing the efcacy of herbal drugs.
48. Shinde, V. M., Dhalwal, K., Potdar, M., & Mahadik, K. R. (2009). Application of quality control prin-
ciples to herbal drugs. International Journal of Phytomedicine, 1(1), 4–8.
49. Sindhu, R. K., Gupta, R., Wadhera, G., & Kumar, P. (2022). Modern herbal nanogels: Formulation, deliv-
ery methods, and applications. Gels, 8(2), 97.
50. Govindaraghavan, S., & Sucher, N. J. (2015). Quality assessment of medicinal herbs and their extracts:
Criteria and prerequisites for consistent safety and efcacy of herbal medicines. Epilepsy & Behavior, 52, 363–371.
51. Gaud, S., Jain, N. K., & Kannojia, P. (2018). Standardization of an Ayurvedic Bhasma preparation and its
evaluation as a potential haematinic agent. Journal of Drug Delivery and Therapeutics, 8(6-A), 19–24.
52. Kumar, R. (2023). Nanotechnology in herbal medicine: Challenges and future perspectives. In
Nanotechnology in Herbal Medicine (pp. 515–548). Woodhead Publishing.
53. Mirzaeian, R., Sadoughi, F., Tahmasebian, S., & Mojahedi, M. (2021). The role of herbal medicines in
health care quality and the related challenges. Journal of Herbmed Pharmacology, 10(2), 156–165.
54. Parveen, B., Parveen, A., Parveen, R., Ahmad, S., Ahmad, M., & Iqbal, M. (2020). Challenges and oppor-
tunities for traditional herbal medicine today, with special reference to its status in India. Annals of Phytomedicine, 9(2), 97–112.
55. Peng, B., Xie, Y., Lai, Q., Liu, W., Ye, X., Yin, L., & Chen, H. (2024). Pesticide residue detection technol-
ogy for herbal medicine: Current status, challenges, and prospects. Analytical Sciences, 40(4), 581–597.
56. Kamel, R. (2021). Contribution of novel delivery systems in the development of phytotherapeutics.
Herbal medicine: Back to the future: Volume 4, Infectious Diseases, 4, 148.
57. Atmakuri, L. R., & Dathi, S. (2010). Current trends in herbal medicines. Journal of Pharmacy Research,
3(1), 109–113.
58. Chiu, P. (2024). Modernity, Pharmacy Law, and The Chinese Pharmacopoeia. In A History of Western
Pharmacy in China (pp. 167–192). Singapore: Springer Nature Singapore.
Historical Development
2
ofHerbal Medicine
Roomah Javed, Maria Faraz, and Arshad Farid
Gomal Center of Biochemistry and Biotechnology, Gomal University, D.I. Khan, Pakistan
Samy Selim
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia

2.1 INTRODUCTION

Herbal medicine (herbalism) refers to plant- based substances that possess nutritional, therapeutic, or preventive properties (Sharma, Sabharwal etal. 2021). It is a fascinating eld that connects herbal medicine and Ayurveda, covering a wide range of areas such as botany, medicinal plant research, pharmacognosy, phytochemistry, phytotherapy, botanical medicines, Ayurveda, natural chemistry, agriculture science, Unani medicine, biotechnology, and biochemistry (Hoffmann 2003). The plant parts used in herbal therapy contain seeds, berries, roots, leaves, fruits, bark, owers, or even whole plants (Pan, Litscher etal. 2014). Herbal medicine dates back to prehistoric times (Qadir and Raja
2021). Early humans used plants for healing, and archaeological evidence supports their acquain­tance of herbal remedies. In the 19th century, the germ theory of disease transformed medicine. Evidence- based practices emerged, leading to pharmaceutical drugs replacing many herbal treat­ments. Despite modern advancements, traditional and alternative medicine systems still incorporate herbs. People pursue natural remedies alongside evidence- based treatments. Historically, the use of herbs and spices in cooking also had medicinal benets. Some compounds in culinary herbs suggest antimicrobial properties (Martínez- Graciá, González- Bermúdez etal. 2015). In recent times, herbal medications have expanded widespread interest due to their various benets. These formulations, resulted from natural herbs, are increasingly documented as effective remedies for various health con­ditions. Surprisingly, despite their unconventional nature, over 80% of the global population depends on herbal products and medicines to maintain well- being (Khan and Ahmad 2019). However, this ow in herbal usage has also led to product manipulations and adulterations, disappointing both consumers and manufacturers and, in some cases, resulting in serious costs. Scientists grapple with the challenge of developing consistent analytical techniques to quantitatively assess marker/bioactive chemicals and other essential ingredients, conrming consistent proling of the phytochemical com­position. Standardization is a critical step in establishing quality control (Verma and Affairs 2016).
In recent times, phytomedicine, also known as herbal medicine, has increased mainstream recogni­tion due to developments in analysis, quality control, and clinical research (Barkat, Goyal etal. 2021). According to the World Health Organization (WHO), phytomedicine incorporates the knowledge, skills, and practices rooted in various cultures (Nigam 2021). These practices, whether scientically explainable or not, contribute to sustaining health and addressing physical and mental illnesses (Organization 2009). Plant- derived substances contain historical herbal medicines that do not require
19
20 Herbal Pharmacopeia
industrial processing. These remedies have been practiced for centuries in local and regional healing traditions. Long before the advent of allopathic drugs, herbal medicines served humanity, with prepa­rations like tinctures, teas, poultices, and powders originating from crude plant materials (Li and Weng 2017; Nasim, Sandeep etal. 2022). The historical use of plants for healing predates registered human history and has had a signicant inuence on the development of modern medicine (Chaachouay, Zidane etal. 2024). Early medications, such as aspirin, digitoxin, morphine, quinine, and pilocarpine, were primarily derived from plant- based sources (Bhardwaj, Verma etal. 2018).
In many developing countries, a signicant portion of the population rely on traditional healers and their stock of medicinal plants to address healthcare needs. Despite the coexistence of modern medicine, herbal remedies endure popular due to historical and cultural factors (Jamshidi- Kia etal.
2017). These products are increasingly accessible commercially, particularly in developed nations. However, some ingredients are now advertised for purposes not originally planned within traditional healing systems. For instance, ephedra is sponsored for weight loss or athletic performance enhance­ment. While certain countries impose stringent manufacturing standards for herbal medicines, this consistency is not universal. In Germany, herbal products sold as ‘phytomedicines’ adhere to the same efcacy, safety, and quality criteria as other drug products (Liu and Salmon 2010). In contrast, in the USA, most herbal products in the market fall under the type of dietary supplements, which do not need pre- approval based on these criteria (Kumar and Kumar 2009).

2.2 PREHISTORY

The prehistoric herbal medicine refers to the period before humans could read and write. During the prehistoric period, human populations were distributed across the world (Balick and Cox
2020). These populations formed isolated communities and cultures that interrelated periodically. Archaeologists have studied the history of herbalism into different periods by considering different factors (Giannenas, Sidiropoulou etal. 2020).
Prehistoric medicine is highly circumstantial, varying based on location and the people involved (Winkelman and Theory 2022). As a result, it represents different levels of societal development according to the period being studied. In archaeology, the study of medicine focused on various techniques such as observing illnesses in the remains of human beings, analyzing plant remnants, and conducting archaeological sites to expose ancient healthcare applications. During this ancient time, people likely combined natural and supernatural methods to treat conditions and diseases (Brown, McIlwraith etal. 2020). While there was no formal research, trial and error played a role. However, due to the lack of antiseptics, proper facilities, and an ignorance of the role of germs, even minor injuries like cuts, bruises, and broken bones could become serious if infected. Additionally, evidence recommends that conditions like osteoarthritis, rickets, and bone deformities existed, likely inuenced by factors such as heavy lifting and malnutrition. Life expectancy was low, with women frequently dying in childbirth. Evidence from prehistoric burial practices suggests some knowledge of bone structure, but public health concepts were likely absent. Interestingly, Neanderthal tombs in Iraq dating back around 60,000 years contain pollen and ower fragments from numerous medicinal plants, highlighting the ancient origins of herbal medicine (Izah, Ogidi etal. 2024). For example, the Neanderthal burial site “Shanidar IV” in northern Iraq revealed the pollen from seven plant species which are still used as herbal remedies (Chazan 2021). Researchers believe that the rodent, Meriones tersicus, played a signicant role in transporting pollen to its current location. This nding underscores the Neanderthals’ knowledge of herbal medicine, as they utilized plants like Ephedra, Centaurea, Senecio, Althea, and Achillea for health purposes (Hunt, Pomeroy etal. 2023). This implies that herbal remedies were widely used during that era.
Similarly, over 5,000 years ago there is that the ‘Iceman’ known as called Otzi had also used medicinal herbs, likely to treat parasites in his intestines. The study of prehistoric medicine provides valuable awareness into the early applications of healing and the role of plants in promoting health and well- being (Qadir and Raja 2021).
Historical Development of Herbal Medicine 21

2.2.1 Ancient civilizAtion

Ancient history of herbalism spans from approximately 3000 BCE to 500 CE (Oberhelman 2020). While the periodization may suggest a uniform history, it’s crucial to recognize that sociocultural norms and technological advancements varied signicantly over this period, both locally and glob­ally (Cruse 2021).
Early civilizations across the world harnessed the healing properties of plants, laying the ground­work for modern herbal medicine (Elendu 2024). Ancient herbal medicine, which also covers a similar timeframe, featured various methods about healing that come from different parts of the world (Sharma etal. 2021). These theories often intertwined nature, religion, and human health, emphasizing concepts of uids and energy mixing. While well- known scholars and important texts offered detailed medical perceptions, which come across several difculties. Early civilizations used a variety of herbs for medicinal purposes (Giannenas, Sidiropoulou etal. 2020). Chamomile, which was used by the ancient Romans and Egyptians, was known for its calming effects and treated digestive issues and insomnia (Sarkar and Chawla 2022). Garlic, which was widely used in ancient Egypt, Greece, and Rome, was valued for its antibacterial properties and used in the treat­ment of infections and respiratory problems (Sayed 2023). Similarly, in ancient China and India, ginger was used to treat nausea, digestive issues, and inammation (Komiljonova 2024). The Romans utilized lavender for its antiseptic and anti- inammatory properties, as well as its calming scent to reduce stress and anxiety (Grecu etal. 2021). Mint was employed by the ancient Greeks and Romans to aid digestion and relieve headaches (Stapley 2023). Turmeric, a key component in Ayurvedic medicine in ancient India, was known for its anti- inammatory and antioxidant proper­ties (Akaberi etal. 2021). Rosemary, used by the ancient Greeks and Romans, was believed to enhance memory and act as an antiseptic (Stapley 2023). The ancient Egyptians called aloe vera the “plant of immortality” and used it for treating wounds and skin conditions. These herbs were essen­tial in ancient medicinal practices and continue to be used in modern herbal medicine (Albahri etal.
2023) (Table 2.1).
TABLE 2.1 Potential Uses of Some Common Herbs
Herbs Scientic Names Potential Uses
Aloe Aloe vera/Aloe barbadense Antibacterial & Moisturizer Cranberry Vaccinium macrocarpon Urinary Health, Heart Health & Diabetes Chameleon Plant Houttuynia cordata Chronic Sinusitis Chamomile Matricaria recutita Digestive Issues & Insomnia Echinacea Coneower Boils, Fever & Herpes Fenugreek Trigonella foenum- graecum Diabetes & Satiety Garlic Allium sativum Heart & Dental Health, Sickle Cell Anemia & Diabetes Ginger Zingiber ofcinale Osteoarthritis, Nausea, Indigestion & Painful Menstruation Ginkgo Ginkgo biloba Cognition, Schizophrenia, Glaucoma, Blood Vessels, Migraines
& Vertigo Green Coffee Bean Coffea Mild Hypertension Lavender Lavandula angustifolia Stress & Anxiety Mint Mentha Digestion & Relieve Headaches Rosemary Improve Memory & Served an Antiseptic Turmeric Curcuma longa Osteoarthritis & Joint Pain Wheatgrass Triticum aestivum Chemotherapy induced Bone Marrow Suppression &
Inammatory Bowel Disease
22 Herbal Pharmacopeia
2.2.1.1 Mesopotamia
Mesopotamia is a region which is situated between the Tigris and Euphrates rivers in the Middle East (Al Bomola 2011). It served as the cradle for some of the world’s earliest civilizations, includ­ing the Sumerians and the Akkadians (a broad classication, which included both the Assyrians and the Babylonians). In early Mesopotamian healing practices, there was an intriguing blend of naturalistic and supernatural beliefs, intertwining medicine, science, magic, and religion (Pouyan
2016).
The earliest recorded evidence of using medicinal plants for drug preparation comes from a Sumerian clay slab discovered in Nagpur, and which dates from the 3rd millennium BCE. These tablets contained detailed information about drug prescriptions, surgical procedures, and even exor­cisms. This ancient artifact, dating back approximately 5,000 years, contains 12 recipes for drug formulations, referencing over 250 different plants. Among these plants are alkaloid- containing spe­cies like poppy, henbane, and mandrake. Additionally, the Indian Vedas, sacred texts, also mention the use of plants for healing, reecting their abundant presence in the country (Singh 2016). Highly specialized professionals, including seers, exorcists, and physician- priests, administered and per­formed these practices. One early example of a prescription- like medication can be found in Sumerian texts from the Third Dynasty of Ur (around 2112 BCE to 2004 BCE).
Following the Akkadian Empire’s conquest of the Sumerian civilization, the Babylonian civiliza­tion gained in prominence. A notable contribution to their medicinal literature was the Diagnostic Handbook, authored by Esagil- kin- apli during the reign of Babylonian king Adadapla- iddina. It provided detailed observations and logical rules for connecting symptoms to diagnoses and progno­ses (Žuškin etal. 2008). Most artifacts from ancient Mesopotamian civilizations originate from the neo- Assyrian and neo- Babylonian periods, offering insights into medical practices despite gaps due to document damage.
In the Mesopotamian civilizations, various medical innovations emerged (Pouyan 2016). These included practices related to prophylaxis (preventing the spread of disease), documentation of strokes, and an awareness of mental illnesses.
2.2.1.2 Ancient Egypt
Ancient Egypt, a remarkable civilization, thrived along the River Nile, which ourished for nearly 30 centuries. However, it faced many challenges: Persian conquests weakened it in 525 BCE, and Alexander marked its ultimate downfall in 332 BCE. Ancient Egyptian texts hold a fascinating allure, especially because of the language and translation debates that surround them (Schiødt
2023). Many translations rely on calculations between ancient and modern concepts, leaving room for uncertainty about conditions and circumstances. Even though physical documents from that his­torical period are very limited, the Papyrus Ebers provide valuable information about ancient herbal practices (Gonzalez 2021).
The Papyrus Ebers contains detailed lists of various health issues and their medications in rela­tions to matters such as skin and limb issues (Von Klein 1905). It comprises the study of various herbal plants such as cannabis, garlic, juniper, aloe, castor bean, and devil’s apple. Actions primarily focused on alleviating prevalent symptoms, as these symptoms were often considered the basic problem. Unfortunately, information about the assortment and preparation of these medications remains mostly unknown. Several translated information conclude that physicians previously have knowledge of treatment techniques, so they don’t restate them explicitly. While our modern under­standing of Egyptian herbals relies on translations of ancient information that spread this tradition to various areas worldwide, manipulating and shaping medical applications sin different cultures (Heinrich etal. 2012; David and Forshaw 2023). This glimpse into ancient Egyptian medicine is invaluable.
Egyptian healers primarily relied on locally sourced herbs, although they did occasionally import some herbs from regions like Lebanon (Abdel- Azim etal. 2011).
Historical Development of Herbal Medicine 23
2.2.1.3 India, China, Greece, & Rome
2.2.1.3.1 India
Ayurveda, India’s traditional healthcare system, dates back over 5,000 years. Ancient sages devel­oped a holistic approach to health and well- being during the Vedic period in India by conning the body, mind, and soul. More than 114 Ayurvedic treatments for various diseases were covered in the ancient book ‘Atharvaveda’.
Ayurveda is an ancient medical system of India, which blends two main strands from different traditions. Ayurveda combines traditional herbal practices with new theories and treatments that started around 600 BCE (Kizhakkeveettil, Parla etal. 2024). The Sushruta Samhita records 700 herbal plants (Jaiswal, Liang etal. 2016) with different treatments about some diseases.
The good health condition and diseases are not pre- planned and can be regulated by the human force, stated that in Charaka Samhita. The information collected from the mentioned books is con­cerned with the examination, diagnosis, treatment, and prognosis of various diseases. Sushruta is famous for his surgical actions, including rhinoplasty, ear lobe repair, lithotomy, and cataract sur­gery, earning him the title “father of plastic surgery” (Champaneria, Workman etal. 2014). It also described over 125 surgical instruments.
Ayurvedic typically contains different categories of medicines such as surgery, psychiatric medi­cine, ENT diseases, toxicology, rejuvenation, and fertility (Chaudhry 2019). Teaching was inte­grated with clinical subjects, such as anatomy with surgery and embryology with pediatrics.
2.2.1.3.2 China
Different plant seeds were used as herbal medicine for several diseases in the Bronze Age Shang dynasty. Shennong Ben Cao Jing, the rst Chinese pharmacopoeia, records 365 herbal plants and (Sheng, Shang etal. 2019) their applications, including Ephedra, Cannabis and Hydnocarpus which is used for the treatment of leprosy.
The Chinese empires signicantly regulate the methods of healing by using traditional Chinese medicine (TCM). This system began developing around the Zhou dynasty and is evident in early texts like the Classic of Changes (Yi Jing) and Classic of Poetry (Shi Jing). Traditional Chinese medicine, rooted in Taoist physicians’ empirical observations, reects the belief that human experi­ences mirror universal principles (Zhan and values 2014). The foundational text, Huangdi Neijing (Yellow Emperor’s Inner Canon), was written between the 5th and 3rd centuries BCE. In the late 2nd century CE, Zhang Zhong Jing’s Treatise on Cold Damage referenced the Neijing Suwen. Huangfu Mi, a Jin dynasty practitioner, also cited the Yellow Emperor in his Jiayijing around 265 CE. The Tang dynasty saw the expansion and revision of the Suwen, solidifying its role in TCM. For thousands of years, TCM has been used for different health treatments through various ways such as surgery and other therapies (Dong and Medicine 2013).
2.2.1.3.3 Greece and Rome
The early Greece exposed the herbal remedies and their recipes about several health problems in the Hippocratic Corpus. In contrast to the religious healing practices of the time, the Corpus nota­bly lacks rites, prayers, or chants, highlighting the Hippocratic emphasis on logic and reason in medicine.
The Corpus mentioned a variety of herbs, some of them imported from distant places such as Arabia (McCabe 2009). Although many imported ingredients were likely too costly for everyday use, some recommended herbs, such as elderberries and St. John’s Wort, were more affordable and accessible (Laird, Laird etal. 2019).
A Greek physician, Galen of Pergamon, was extremely creative in detailing his medical knowl­edge in Rome about herbalism. Among his many writings on herbs and their properties, his most notable work is the “Works of Therapeutics.” Galen discusses the integration of various medical disciplines to rehabilitate and treat health- related problems. Diocles of Carystus was a well- respected